MicroPulse® and PASCAL® in the world of retinal treatments
3 September, 09.45 – 10.45 CEST
Hall E
Chairperson(s):
S. Vujosevic ITALY
Durability across indications: Seeing from the patient’s perspective
3 September, 09:45 – 10:45 CEST
Hall 4
Chairperson(s):
G. Cheung SINGAPORE &
V. Chaudhary CANADA
A vision of the future: The next level in patient care
3 September, 13.45 – 14.45 CEST
Hall 1
Chairperson(s):
N. Eter GERMANY
Broadening management options for DME: Recent clinical insights from targeting dual inhibition of Ang-2 and VEGF-A
3 September, 13.45 – 14.45 CEST
Hall 3
Chairperson(s):
J-F Korobelnik FRANCE
Wide field swept source OCT: Learn from our experts!
3 September, 13.45 – 14.45 CEST
Hall X1
Chairperson(s):
P. Stanga UK
Preserving patient health: the retina and beyond
3 September, 13.45 – 14.45 CEST
Hall G1
Chairperson(s):
C. Delcourt FRANCE & T. Aslam UK
Driving Efficiency & Performance through Visionary Technology
3 September, 13.45 – 14.45 CEST
Hall E
Chairperson(s):
T. Williamson UK
Experience From The Clinic: Management of Neovascular AMD Patients in 2022
3 September, 13.45 – 14.45 CEST
Hall 4
Chairperson(s):
R. Khoramnia GERMANY
Fine-Tune your Vitreoretinal Surgery – How to get the best view for you and your patients
3 September, 13.45 – 14.45 CEST
Hall X2
Chairperson(s):
P. Stalmans BELGIUM
The future of geographic atrophy: advancing diagnosis, treatment and management
3 September, 13.45 – 14.45 CEST
Hall G2
Chairperson(s):
P. Udaondo SPAIN
nAMD Treatment Fundamentals IME Platform: Pearls for a Proactive and Individualized nAMD Treatment Approach with Modern Therapeutics
3 September, 17.45 – 18.45 CEST
Hall 4
Chairperson(s):
A. Loewenstein ISRAEL
Retinale® – EURETINA Kompakt
3 September, 17.45 – 18.45 CEST
Hall X2
Chairperson(s):
N. Feltgen GERMANY